Pfizer Acquires Seagen: What Does This Multibillion-Dollar Deal Mean for the Biotech Industry?
A $43 billion deal has been reached between Pfizer and Seagen. The Wall Street Journal reported that Pfizer has agreed to pay USD 43 billion for biotech Seagen and its pioneering cancer drugs. In the deal, Pfizer will pay USD 229 in cash per share, according to the drugmaker. The deal, which includes debt, is […]